5-(溴甲基)-1-甲基-2(1H)-喹啉酮 | 133032-60-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 5-(溴甲基)-1-甲基-2(1H)-喹啉酮
• 英文名称: 5-Bromomethyl-1-methyl-2-oxo-1,2-dihydroquinoline
• 英文别名: 5-bromomethyl-1,2-dihydro-1-methylquinolin-2-one；5-(bromomethyl)-1-methylquinolin-2(1H)-one；5-(bromomethyl)-1-methylquinolin-2-one
• CAS: 133032-60-7
• 化学式: C₁₁H₁₀BrNO
• 分子量: 252.11
• InChiKey: ONFPQUPIBGQIRZ-UHFFFAOYSA-N

物化性质

• 沸点：
  350.6±42.0 °C(Predicted)
• 密度：
  1.513±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5-(溴甲基)-1-甲基-2(1H)-喹啉酮 、 4-(3-hydroxyphenyl)-4-methoxy-3,4,5,6-tetrahydro-2H-pyran 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以56%的产率得到5-[3-(4-Methoxy-tetrahydro-pyran-4-yl)-phenoxymethyl]-1-methyl-1H-quinolin-2-one
  参考文献：
  名称：

  甲氧基四氢吡喃。一系列新的选择性和口服有效的5-脂氧合酶抑制剂。

  摘要：

  对（甲氧基烷基）噻唑1- [3-（萘-2-基甲氧基）苯基] -1-噻唑-2-基丙基甲基醚（1，ICI 211965）的SAR的研究导致了新系列的甲氧基四氢吡喃母体化合物4- [3-（萘-2-基甲氧基）苯基] -4-甲氧基-3,4,5,6-四氢-2H-吡喃（4f）为代表的5-脂氧合酶（5-LPO）抑制剂的制备。体外4f抑制了酵母聚糖刺激的无血浆小鼠巨噬细胞中白三烯C4（LTC4）的合成，以及A-23187刺激的人全血中的LTB4合成（IC50分别为0.5 nM和0.07 microM）。在大鼠中，在每个系统口服10 mg / kg后3小时，ED 4抑制了离体血液和经酵母聚糖发炎的空气囊渗出液中LTB4的合成，时间为ED50。在寻求更有效的口服活性化合物时，在4f同类产品中探索了在不牺牲效能的情况下降低亲脂性的策略。例如，用各种氮杂和氧杂环代用品取代4f的2-萘基，得到的化合物的log P降低了1

  DOI：

  10.1021/jm00092a010

文献信息

• Heterocycles for use as inhibitors of leukotrienes
  申请人：Imperial Chemical Industries PLC

  公开号：US05134148A1

  公开（公告）日：1992-07-28

  The invention concerns a heterocycle of the formula I ##STR1## wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; A is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene; X is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms; R.sup.1 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X.sup.2 --A.sup.3 -- which, together with the carbon atom to which A.sup.2 and A.sup.3 are attached, defines a ring having 4 to 7 ring atoms, wherein A.sup.2 and A.sup.3, which may be the same or different, each is (1-4C)alkylene and X.sup.2 is oxy, thio, sulphinyl, sulphonyl or imino; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  该发明涉及式I的杂环##STR1##其中Q是一个可选择地取代的含有一个或两个氮原子的6元单环或10元双环杂环基团；A是(1-6C)烷基、(3-6C)烯基、(3-6C)炔基或环(3-6C)烷基；X是氧、硫、亚砜基、磺酰基或亚胺基；Ar是苯基，可以选择性地带有一个或两个取代基，或Ar是一个可选择地取代的含有最多三个氮原子的6元杂环基团；R.sup.1是氢、(1-6C)烷基、(3-6C)烯基、(3-6C)炔基、氰基-(1-4C)烷基或(2-4C)烷酰基，或可选择地取代的苯甲酰基；而R.sup.2和R.sup.3一起形成一个式--A.sup.2--X.sup.2--A.sup.3--的基团，与A.sup.2和A.sup.3连接的碳原子一起定义具有4到7个环原子的环，其中A.sup.2和A.sup.3，可以相同也可以不同，每个是(1-4C)烷基，而X.sup.2是氧、硫、亚砜基、磺酰基或亚胺基；或其药学上可接受的盐。该发明的化合物是5-脂氧合酶的抑制剂。
• Heterocyclic cycloalkanes
  申请人：Imperial Chemical Industries PLC

  公开号：US05217977A1

  公开（公告）日：1993-06-08

  The invention concerns a heterocyclic cycloalkane of the formula I ##STR1## wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; A is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene; X is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms; R.sup.1 is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R.sup.2 and R.sup.3 together form a (3-6C)alkylene group which, together with the carbon atom to which R.sup.2 and R.sup.3 are attached, defines a ring having 4 to 7 ring atoms, and which ring may bear one or two substituents; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  该发明涉及一种异环脂环烷化合物，其化学式为I，其中Q是含有一个或两个氮原子的可选取代的6元单环或10元双环杂环基团；A是(1-6C)烷基，(3-6C)烯基，(3-6C)炔基或环(3-6C)烷基；X是氧，硫，亚砜基，砜基或亚胺基；Ar是苯基，可以选择性地带有一个或两个取代基，或Ar是含有最多三个氮原子的可选取代的6元杂环基团；R.sup.1是氢，(1-6C)烷基，(3-6C)烯基，(3-6C)炔基，氰基-(1-4C)烷基或(2-4C)酰基，或可选择性取代的苯甲酰基；而R.sup.2和R.sup.3一起形成一个(3-6C)烷基基团，与R.sup.2和R.sup.3连接的碳原子一起定义一个具有4到7个环原子的环，并且该环可能带有一个或两个取代基；或其药用可接受盐。该发明的化合物是5-脂氧合酶的抑制剂。
• Heterocyclic cyclic ethers
  申请人：Imperial Chemical Industries PLC

  公开号：US05196419A1

  公开（公告）日：1993-03-23

  The invention concerns a heterocyclic cyclic ether of the formula I ##STR1## wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; A is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene; X is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms; R.sup.1 and R.sup.2 together form a group of the formula --A.sup.2 --X.sup.2 --A.sup.3 -- which, together with the oxygen atom to which A.sup.2 is attached and with the carbon atom to which A.sup.3 is attached, defines a ring having 5 to 7 ring atoms, wherein A.sup.2 and A.sup.3 each is (1-3C)alkylene and X.sup.2 is oxy, thio, sulphinyl, sulphonyl or imino, and which ring may bear one, two or three substituents; and R.sup.3 is hydrogen, (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl or substituted (1-4C)alkyl; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  该发明涉及一种具有以下式I的杂环环氧化物 其中Q是含有一个或两个氮原子的可选择取代的6-成员单环或10-成员双环杂环基; A是(1-6C)烷基，(3-6C)烯基，(3-6C)炔基或环(3-6C)烷基; X是氧，硫，亚砜，磺酰基或亚胺; Ar是苯基，可能可选择携带一个或两个取代基，或Ar是一个可选择取代的含有最多三个氮原子的6-成员杂环基; R1和R2一起形成一个具有以下式--A2--X2--A3--的基团，与A2连接的氧原子和与A3连接的碳原子一起，定义具有5至7个环原子的环，其中A2和A3各自是(1-3C)烷基，X2是氧，硫，亚砜，磺酰基或亚胺，该环可以携带一个、两个或三个取代基; R3是氢，(1-6C)烷基，(2-6C)烯基，(2-6C)炔基或取代的(1-4C)烷基;或其药用盐。该发明的化合物是5-脂氧合酶的抑制剂。
• Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
  申请人：ZENECA LIMITED

  公开号：US20020040002A1

  公开（公告）日：2002-04-04

  1 Compounds of formula (I), wherein: n is 1 to 6; Het is a nitrogen containing ring fused to the benzene ring on two adjacent carbon atoms to form a bicyclic ring system which ring system may be optionally substituted; R 1 is hydrogen, C 1-8 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-8 cycloalkyl, aryl, heteroaryl, heterocyclyl, arylC 1-6 alkyl, heteroarylC 1-6 alkyl, heterocyclylC 1-6 alkyl or C 3-8 cycloalkylC 1-6 alkyl; R 2 is C 1-6 alkyl, C 2-6 alkenyl, arylC 1-6 alkyl, heteroarylC 1-6 alkyl or the side-chain of a naturally occurring amino acid; R 3 is hydrogen, C 1-6 alkyl, C 3-8 cycloalkyl, C 4-8 cycloalkenyl, arylC 1-6 alkyl, heteroarylC 1-6 alkyl or heterocyclylC 1-6 alkyl; R 4 is hydrogen or C 1-6 alkyl; or R 3 and R 4 together with the nitrogen atom to which they are joined form a heterocyclic ring; wherein any group or ring, in R 1 -R 4 , is optionally substituted; and pharmceutically acceptable salts and in vivo hydrolysable esters thereof, are described as inhibitors of the production of Tumour Necrosis Factor and/or one or more matrix metalloproteinase enzymes. Compositions containing them and their preparation are also described.

  化合物的式子(I)，其中：n为1至6；Het是一个氮含环，在苯环上的两个相邻碳原子上融合形成一个双环系统，该环系统可以选择性地被取代；R1为氢、C1-8烷基、C2-6烯基、C2-6炔基、C3-8环烷基、芳基、杂芳基、杂环基、芳基C1-6烷基、杂芳基C1-6烷基、杂环基C1-6烷基或C3-8环烷基C1-6烷基；R2为C1-6烷基、C2-6烯基、芳基C1-6烷基、杂芳基C1-6烷基或天然氨基酸的侧链；R3为氢、C1-6烷基、C3-8环烷基、C4-8环烯基、芳基C1-6烷基、杂芳基C1-6烷基或杂环基C1-6烷基；R4为氢或C1-6烷基；或者R3和R4与它们连接的氮原子一起形成一个杂环；其中R1-R4中的任何基团或环都可以选择性地被取代；并且其药学上可接受的盐和体内可水解的酯被描述为肿瘤坏死因子和/或一个或多个基质金属蛋白酶酶的生产抑制剂。还描述了含有它们的组合物及其制备方法。
• Heterocyclic cycloalkanes as inhibitors of 5-lipoxygenase
  申请人：ZENECA LIMITED

  公开号：EP0385663A2

  公开（公告）日：1990-09-05

  The invention concerns a heterocyclic cycloalkane of the formula I wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; A is (1-6C)alkylene, (3-6C)alkenylene, (3-6C)alkynylene or cyclo(3-6C)alkylene; X is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms; R¹ is hydrogen, (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R² and R³ together form a (3-6C)alkylene group which, together with the carbon atom to which R² and R³ are attached, defines a ring having 4 to 7 ring atoms, and which ring may bear one or two substituents; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.

  本发明涉及式 I 的杂环环烷 其中 Q 是任选取代的 6 元单环或 10 元双环杂环分子，含有一个或两个氮原子；A 是 (1-6C)亚烷基、(3-6C)烯基、(3-6C)炔基或环(3-6C)亚烷基； X 是氧基、硫代、亚砜基、磺酰基或亚氨基；Ar 是苯基，可任选带有一个或两个取代基，或者 Ar 是任选被取代的 6 元杂环分子，最多含有三个氮原子； R¹是氢、(1-6C)烷基、(3-6C)烯基、(3-6C)炔基、氰基-(1-4C)烷基或(2-4C)烷酰基，或任选取代的苯甲酰基；以及R²和R³共同形成一个(3-6C)亚烷基，该亚烷基与R²和R³所连接的碳原子一起定义了一个具有4至7个环原子的环，该环可带有一个或两个取代基；或其药学上可接受的盐。 本发明的化合物是 5-脂氧合酶的抑制剂。